Experiencing a traumatic brain injury can increase chances of dementia by up to 80 percent, even decades after the injury occurred, according to a…
When LaVonne Moore, 85, entered Ohio State University’s Wexner Medical Center study on slowing the decline of problem solving in Alzheimer’s patients, she had lost…
One of the topics caregivers of an Alzheimer’s patient ask about most is sleep patterns. We know that Alzheimer’s can cause changes in the…
Another Alzheimer’s drug has failed in a phase 3 trial, the stage right before drugs go to the Food and Drug Administration for approval….
Considering the growing evidence that Alzheimer’s can manifest early as sensory problems like sight and hearing loss, it’s not surprising that many Alzheimer’s caregivers…
The leading theory in Alzheimer’s disease is that memory loss is the result of neuron death and nerve ending damage, which lead to memory…
A new study has found that hundreds of thousands of people with dementia could experience an improved life with a simple, non-drug medicine: music….
For some, a diagnosis of mild cognitive impairment (MCI) can feel like a death sentence. After all, about half of those diagnosed with the…
Salt: Our bodies need it to function, but too much sodium can have dire consequences for cardiovascular health, like stroke, mounting research shows. Researchers at…
Creeping levels of stress and anxiety could be a sign of impending Alzheimer’s disease, a new study has found. Scientists at Brigham and Women’s…
Scientists have finally cracked the code of how an experimental new drug called J147, which has a proven track record of reversing Alzheimer’s disease…
It hasn’t been a good week for Alzheimer’s drug development. Pfizer, one of the world’s biggest pharmaceutical companies, announced that they would abandon the…
In the absence of a treatment for Alzheimer’s disease, researchers are turning to out-of-the-box approaches to slow or ease the progression of the disease….
Pfizer is ceasing its research into Alzheimer’s and Parkinson’s medications. While Pfizer is cutting its development of Alzheimer’s and Parkinson’s medications, advocacy groups remain…
New advances in brain imaging have allowed scientists from Cambridge University to track how tau, a protein that accumulates in the brain in Alzheimer’s…